India’s bio-economy has grown 13-fold in the last decade — from $10 billion in 2014 to over $130 billion in 2024, Union Minister of State (Independent Charge) for Science & Technology, said Jitendra Singh said on Wednesday.
Addressing the 17th Annual International Biocuration Conference (AIBC-2024) at the Regional Centre for Biotechnology in Faridabad, the Minister said that the country is now being rated among the top 12 biotechnology destinations in the world.
“India has reached nearly 6,000 bio-startups from 50 in the past 10 years,” Jitendra Singh said.
“It is the best time for biotechnology, highlighting the progress of biotechnology in India,” he added.
He also noted that India is now globally known for preventive healthcare.
The country has developed the first-ever DNA vaccine for Covid-19, and is now making its first ever vaccine for Human Papilloma Virus (HPV), which will be administered to all school-going adolescent girls to prevent them from cervical cancer.
“The world acknowledges India’s progress in robust vaccine development capacity which has been proved during the Covid pandemic, and India is hailed as a global leader in preventive healthcare,” Jitendra Singh said.
On the 4th death anniversary of human rights activist Karima Baloch, the Baloch Yakjehti Committee…
External Affairs Minister S Jaishankar will visit the US from December 24-29 to discuss key…
Students at the Bolan Medical College (BMC) in Balochistan's Quetta entered the 27th day of…
The intensifying cutting of trees for firewood in Pakistan-occupied Gilgit-Baltistan (PoGB) is not only worsening…
A group of retired judges, bureaucrats, Army officials and other civil society members have penned…
Israel and Slovakia signed a 2 billion shekel (USD 582 million) agreement on Monday to…